Form 4: Delcath Systems Director Czerepak Acquires Stock Options

Elizabeth Czerepak, a director of Delcath Systems, Inc., reports the acquisition of stock options.

Summary

• Elizabeth Czerepak, a director at Delcath Systems, Inc. (DCTH), filed a Form 4 on May 19, 2025.
• The report details the acquisition of 22,500 stock options on May 15, 2025, at an exercise price of $16.05.
• The options vest monthly over one year, starting May 15, 2025, contingent on continued service as a director.
• The options expire 10 years from the grant date or two years after the last day of service, whichever is earlier.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it is a standard regulatory filing regarding stock option grants.

Positives

• The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedule of the options is contingent on continued service as a director.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

• The acquisition of stock options by a director may have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Delcath Systems, DCTH, stock options, Form 4, director, Elizabeth Czerepak, insider trading